These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 23903222

  • 1. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D, Christopoulos A, Sexton PM.
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD, Ulven T, Milligan G.
    Curr Top Med Chem; 2013 Aug; 13(1):14-25. PubMed ID: 23409763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR, Thakur GA.
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M, Bender E, Schamberger J, Eitner F.
    Int J Mol Sci; 2021 Feb 10; 22(4):. PubMed ID: 33578942
    [Abstract] [Full Text] [Related]

  • 12. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL, Burford NT, Li Z, Alt A.
    Methods Mol Biol; 2015 Feb 10; 1335():223-40. PubMed ID: 26260604
    [Abstract] [Full Text] [Related]

  • 13. [G-protein-coupled receptors targeting: the allosteric approach].
    Sebag JA, Pantel J.
    Med Sci (Paris); 2012 Oct 10; 28(10):845-51. PubMed ID: 23067415
    [Abstract] [Full Text] [Related]

  • 14. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M, Hedderich JB, Kolb P, Hilger D.
    Pharmacol Ther; 2022 Sep 10; 237():108242. PubMed ID: 35863587
    [Abstract] [Full Text] [Related]

  • 15. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI, Lewis RJ.
    Biochem Pharmacol; 2013 Jan 15; 85(2):153-62. PubMed ID: 22975406
    [Abstract] [Full Text] [Related]

  • 16. Is there a common allosteric binding site for G-protein coupled receptors?
    Malik F, Li Z.
    J Comput Aided Mol Des; 2022 Jun 15; 36(6):405-413. PubMed ID: 35507106
    [Abstract] [Full Text] [Related]

  • 17. Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs.
    Digby GJ, Conn PJ, Lindsley CW.
    Curr Opin Drug Discov Devel; 2010 Sep 15; 13(5):587-94. PubMed ID: 20812150
    [Abstract] [Full Text] [Related]

  • 18. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P, Gaiser BI, Sejer Pedersen D.
    J Med Chem; 2017 May 25; 60(10):4126-4134. PubMed ID: 28140580
    [Abstract] [Full Text] [Related]

  • 19. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA, Chen J, Cunningham KA, Zhou J.
    J Med Chem; 2019 Jan 10; 62(1):88-127. PubMed ID: 30106578
    [Abstract] [Full Text] [Related]

  • 20. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
    Wootten D, Miller LJ.
    Annu Rev Pharmacol Toxicol; 2020 Jan 06; 60():89-107. PubMed ID: 31454292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.